SOLV News and Press, Solventum Corporation

Solventum to Participate in the 2026 KeyBanc Healthcare Forum PR Newswire ST. PAUL, Minn. , March 11, 2026 /PRNewswire/ --  Solventum (NYSE: SOLV) announced today that management will participate in a virtual fireside chat at the KeyBanc Healthcare Forum on Wednesday, Mar. ...

The Middleby Corporation (NASDAQ: MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. “We are pleased to we...

2026-03-02 20:00:00 ET Shares of Solventum ( SOLV ) have been trading sideways for a while now as investors keep assessing the impact of the full separation from its former parent. Stranded parent costs have caused some surprises (both up and down) since the separation, which wa...

2026-02-27 03:08:36 ET More on Solventum Corporation Solventum Corporation (SOLV) Q4 2025 Earnings Call Transcript Solventum Corporation 2025 Q4 - Results - Earnings Call Presentation Solventum's Self-Help Is Ahead Of Schedule, But Sentiment Is Not Solventum ...

2026-02-27 03:07:52 ET Solventum Corporation (SOLV) Q4 2025 Earnings Call February 26, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Solventum Corporation (SOLV) Q4 2025 Earnings Call Transcript

2026-02-26 18:30:11 ET Image source: The Motley Fool. Thursday, February 26, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-26 16:39:34 ET More on Solventum Corporation Solventum's Self-Help Is Ahead Of Schedule, But Sentiment Is Not Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Solventum Corporation Q4 2025 Earnings Preview ...

Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance PR Newswire Reported sales decreased 3.7%; organic sales increased 3.5% Introduces full-year 2026 organic sales growth, adjusted EPS and free cash flow guidance ST. PAUL, Minn. , Feb...

Evertec Inc. (EVTC) is expected to report $0.81 for Q4 2025 BioCryst Pharmaceuticals Inc. (BCRX) is expected to report $0.06 for Q4 2025 FTI Consulting Inc. (FCN) is expected to report $1.38 for Q4 2025 Arbe Robotics Ltd. (ARBE) is expected to report $-0.1 for Q4 2025 Aclaris Ther...

Solventum Corporation (SOLV) is expected to report $1.5 for Q4 2025